For decades, Customer Relationship Management (CRM) systems in the pharmaceutical industry were designed with a single goal: to track sales activities. They served as digital logbooks for field representatives - recording visits, calls, and prescription data. But today, the industry is undergoing a profound shift. CRM has moved far beyond sales tracking to become a strategic platform for&nbsp;value creation,&nbsp;patient engagement, and&nbsp;evidence-based decision making.The question for pharma is no longer&nbsp;“What did our sales team do?”&nbsp;- it is&nbsp;“How are we delivering meaningful value to healthcare providers (HCPs), patients, and the wider care ecosystem?”<h2>The Early Days: CRM as a Sales Control Tool</h2>Historically, CRM in pharma focused primarily on:<ul><li>Call tracking and rep scheduling</li><li>Basic reporting on prescription trends</li><li>Monitoring sales force productivity</li></ul>These systems were transactional. Communication was one-directional—from pharma to physicians - with limited capacity for insight, personalization, or true relationship building.<h2>The Shift: From Activity Tracking to Engagement</h2>As healthcare evolved, so did expectations from HCPs and patients. Personalized medicine, digital health platforms, and omnichannel communication forced pharma to rethink CRM.Pharma began asking:<ul><li>How do physicians prefer to engage - with digital, in-person, or hybrid touchpoints?</li><li>What information do patients and caregivers find valuable?</li><li>How can we strengthen trust, not just frequency?</li></ul>Digital transformation moved CRM from a simple repository to an&nbsp;integration hub connecting marketing, medical affairs, commercial teams, and patient support.The New Paradigm: CRM as a Value Creation EngineModern CRM platforms are now designed to deliver outcomes, not just record activities. They integrate data from electronic health records (EHR), patient support programs, real-world evidence, and digital therapeutics - empowering pharma companies to build long-term relationships, not one-time transactions.<figure class="table" style="float:left;"><table style=";"><colgroup><col style="width:50%;"><col style="width:50%;"></colgroup><tbody><tr><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Then: Sales Tracking</td><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Now: Value Creation</td></tr><tr><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Call logs &amp; visit frequency</td><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">End-to-end HCP &amp; patient journey mapping</td></tr><tr><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Static dashboards</td><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Predictive insights &amp; recommendations</td></tr><tr><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Sales-centric</td><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Care-centric &amp; outcome-driven</td></tr><tr><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Siloed commercial view</td><td style="border:0.5pt solid #000000;padding:5pt;vertical-align:top;">Integrated medical, marketing &amp; patient insights</td></tr></tbody></table></figure> &nbsp;<h2>Real-World Proof: Why Transformation Is Urgent</h2>Despite massive investment, traditional CRMs are failing to deliver the value modern healthcare demands:80% of pharma companies are disappointed with their CRM’s ability to generate meaningful HCP engagement Pharma invests&nbsp;over US$4.4 billion annually in CRM platforms (ZS Associates report)Yet, leading innovators show what’s possible with evolved, AI-driven CRM:A global pharma firm using AI-powered CRM personalization achieved&nbsp;25% higher HCP satisfaction and&nbsp;15% sales uplift (CloseUp CRM Report)Sales teams using predictive CRM "Next Best Action" achieved&nbsp;1.5× higher performance, and clinics supported by dynamic engagement saw&nbsp;30% faster therapy adoption (IntuitionLabs Case Study)These cases confirm a critical truth:&nbsp;The value of CRM lies not in logging interactions, but in shaping better care decisions.<h2>The Rise of AI, Data &amp; Predictive Engagement</h2>Modern CRM is becoming an intelligent ecosystem powered by:<ul><li>AI-based recommendations for next best action</li><li>Omnichannel coordination (field, email, webinars, MSL outreach)</li><li>360° HCP insights integrating behavior, preferences, treatment focus</li><li>Patient journey support through adherence, education, and feedback tools</li></ul>The next generation of CRM moves from&nbsp;“informing sales” to&nbsp;“orchestrating relationships.”<h2>How VMO Accelerates the Future of Pharma CRM</h2>At&nbsp;VMO, we partner with pharmaceutical and healthcare organizations to modernize CRM with intelligence, integration, and industry compliance.We support clients to:<ul><li>Build AI-driven engagement models for HCP and patient personalization</li><li>Integrate CRM with clinical systems, patient apps, and RWE/medical data&nbsp;</li><li>Develop digital platforms for Medical Affairs &amp; Patient Support Programs</li><li>Enable HIPAA/GDPR-compliant architectures for global scalability</li></ul>VMO goes beyond implementation - we help pharma move from&nbsp;systems of record to systems of impact.<h2>Conclusion: From Selling to Serving</h2>The evolution of CRM in pharma reflects a deeper transformation—from transactional selling to long-term relationship building focused on&nbsp;trust, outcomes, and care.The future belongs to companies that ask:“How do we support physicians and patients better—not just how do we sell more?”CRM is no longer just a commercial tool. It is becoming a strategic engine for meaningful healthcare value.At VMO, we believe the real evolution of CRM is human: empowering better decisions, better connections, and better care.

The question for pharma is no longer “What did our sales team do?” - it is “How are we delivering meaningful value to healthcare providers (HCPs), patients, and the wider care ecosystem?”

From Sales Tracking to Value Creation: The Evolution of CRM in Pharma

from-sales-tracking-to-value-creation-the-evolution-of-crm-in-pharma

In healthcare, technology isn’t just about innovation; it’s about&nbsp;accuracy, safety, and trust. Whether you’re building an AI-powered diagnostic platform, a telemedicine app, or a clinical data system, the success of your project depends on one critical decision:&nbsp;choosing the right tech partner.But with hundreds of vendors claiming healthcare expertise, how can you tell who truly understands both&nbsp;technology and clinical reality?<h3>1. Proven Healthcare Experience: Beyond Buzzwords</h3>When evaluating potential partners, look for&nbsp;proven experience across actual healthcare projects, not just generic software builds. The right partner should:<ul><li>Have delivered solutions in&nbsp;regulated healthcare environments (HIPAA, GDPR, PDPA, ISO 13485).</li><li>Understand the&nbsp;end-to-end healthcare journey from patient data intake and diagnostics to analytics, claims, and reporting.</li><li>Show experience integrating with&nbsp;EHR, PACS, LIS, or HIS systems using standards like&nbsp;FHIR, HL7, and DICOM.</li><li>Demonstrate success in&nbsp;AI-driven healthcare use-cases, such as diagnostic imaging, disease prediction, and patient engagement tools.</li><li>Provide references or case studies proving measurable&nbsp;clinical or operational impact.</li></ul>Example: A true healthcare tech expert won’t just train an AI model; they’ll know how to validate it using anonymized medical datasets, design explainable outputs for clinicians, and comply with regulatory audit processes.<h3>2. Regulatory and Security Competence</h3>Your partner must understand medical data privacy at its core:<ul><li>Apply&nbsp;end-to-end encryption, role-based access, and secure data transmission.</li><li>Comply with&nbsp;HIPAA, GDPR, PDPA, and international standards like&nbsp;ISO 27001 / ISO 13485.</li><li>Support&nbsp;traceability, audit trails, and anonymization for sensitive data.</li></ul>A single compliance gap can stop an entire deployment or, worse, expose patient information.<h3>3. Interdisciplinary Team</h3>Great healthcare solutions are built by teams that combine&nbsp;AI and clinical intelligence. Look for partners who can bring together:<ul><li>AI/ML engineers who understand medical imaging and data modeling</li><li>Data engineers who build secure healthcare data pipelines</li><li>UX experts who design for doctors and nurses, not just end-users</li><li>Regulatory specialists who ensure compliance through every phase</li><li>Medical advisors who validate real-world relevance</li></ul><h3>4. Integration &amp; Interoperability Mindset</h3>Healthcare systems are complex. EHRs, labs, devices, and insurance platforms often speak different “languages.” The right partner builds for&nbsp;interoperability, not isolation:<ul><li>Supports&nbsp;FHIR, HL7, and DICOM standards</li><li>Ensures seamless connection between internal hospital systems and external partners</li><li>Designs architecture that scales with future integrations</li></ul>A good system connects people and data, not just software and servers.<h3>5. Long-Term Partnership and Innovation Mindset</h3>Technology in healthcare evolves fast. The right partner doesn’t walk away after launch — they&nbsp;stay to optimize, scale, and adapt. They should help you:<ul><li>Expand into predictive analytics, patient engagement, or remote monitoring</li><li>Evolve with new compliance frameworks</li><li>Continuously improve data quality and system resilience</li></ul>In healthcare, success isn’t a one-time delivery. It’s a&nbsp;long-term relationship built on reliability and innovation.<h3>Why VMO Healthcare</h3>At&nbsp;VMO (part of the ALTEN Group), we combine&nbsp;deep healthcare expertise with world-class engineering to help clients innovate safely and effectively.Our strengths include:<ul><li>Clinical-grade AI &amp; Data Engineering - delivering intelligent, interoperable, and secure healthcare solutions</li><li>Compliance-first approach - HIPAA, GDPR, and PDPA-ready systems</li><li>Global reach, local agility - blending ALTEN’s global experience with VMO’s strong presence in APAC</li></ul>We don’t just build technology - we&nbsp;co-create healthcare innovation that improves outcomes, reduces friction, and scales globally. &nbsp;

In healthcare, technology isn’t just about innovation; it’s about accuracy, safety, and trust.
 Whether you’re building an AI-powered diagnostic platform, a telemedicine app, or a clinical data system, the success of your project depends on one critical decision: choosing the right tech partner.

What to Look for in a Tech Partner for Your Next Healthcare Project

what-to-look-for-in-a-tech-partner-for-your-next-healthcare-project

On October 9, 2025, VMO was proudly recognized among the Top 10 Providing Global Digital Service 2025 at the Top 10 and Vietnam Digital Technology Enterprises Map 2025 Awards Ceremony, organized by the Vietnam Software and IT Services Association (VINASA).<figure class="image"><img src="https://vmo-ho-web-global.s3.ap-southeast-1.amazonaws.com/vmogroup-global/uploads/1760065709962-DSC03191%20%281%29.jpg"></figure>VMO was specially acknowledged in the following categories:<ul><li>Top 10 Providing Global Digital Service&nbsp;</li><li>Top 10 Providing Global Digital Service by Workforce Size (over 1,000 employees)</li><li>Top 10 Providing Global Digital Service in the Japanese Market</li></ul>This year’s awards celebrate enterprises with outstanding technological capabilities, high-quality products and services, as well as the ability to expand into global markets and meet diverse international client needs. The recognition reflects VMO’s significant contributions to advancing digital services and promoting global integration.This achievement further reinforces VMO’s Vision - Mission - Core Values, serving as a driving force for continuous improvement and the delivery of exceptional services to clients, while contributing to the global prominence of Vietnam’s IT industry. &nbsp;

VMO Honored as Top 10 Providing Global Digital Service 2025

vmo-honored-as-top-10-providing-global-digital-service-2025

<h2>AI for Sepsis Early Detection: Saving Lives with Speed</h2>Sepsis, a life-threatening condition caused by the body’s extreme response to infection, remains one of the most urgent challenges in healthcare. Every hour of delayed treatment significantly increases mortality risk. Traditional methods of detection often rely on visible symptoms, such as fever, rapid breathing, or low blood pressure, which may appear only when the patient’s condition has already worsened.This is where&nbsp;Artificial Intelligence (AI) steps in. By analyzing subtle, continuous changes in patient data, AI can detect early warning signs of sepsis long before they become obvious to clinicians.<h2>How AI Detects Sepsis Earlier</h2>AI-powered systems can:<ul><li>Continuously monitor vital signs, lab results, and clinical notes in real time.</li><li>Identify hidden patterns that may go unnoticed by human observation.</li><li>Generate predictive alerts hours before traditional detection methods, giving clinicians critical time to intervene.</li><li>Integrate with hospital systems such as EMRs and patient monitoring platforms for seamless adoption. &nbsp;</li></ul>Hospitals adopting AI-driven models have reported earlier recognition of sepsis, sometimes&nbsp;up to 6 hours in advance, which enables faster treatment and significantly improves survival rates.<h2>Real-World Impact</h2><ul><li>Epic &amp; UPMC: AI models identified sepsis risk 6 hours earlier than standard protocols, accelerating patient care.</li><li>Kaiser Permanente: AI alert systems increased recognition of impending severe sepsis by 21%.</li><li>Pfizer &amp; Dascena: AI-driven models predicted sepsis progression with 95% accuracy using electronic health records.</li></ul>These results show how AI transforms early detection from a reactive to a&nbsp;proactive, life-saving approach.<h2>Why It Matters</h2>The earlier sepsis is detected, the greater the chance of preventing organ failure and death. AI doesn’t replace doctors, it empowers them with timely insights, making healthcare more&nbsp;precise, responsive, and effective.<h2>Where VMO Can Help</h2>At&nbsp;VMO, we have witnessed the transformative power of AI in healthcare. VMO has been part of the&nbsp;ALTEN Group, a global leader in IT &amp; engineering with more than&nbsp;58,000 experts worldwide and strong experience in life sciences - serving top clients such as Novartis, Johnson &amp; Johnson, Roche, Sanofi, and more.This global expertise, combined with VMO’s strong engineering capabilities, enables us to deliver&nbsp;AI-driven healthcare solutions that integrate seamlessly into clinical workflows while meeting international compliance standards (HIPAA, GDPR, PDPA).

Sepsis, a life-threatening condition caused by the body’s extreme response to infection, remains one of the most urgent challenges in healthcare. Every hour of delayed treatment significantly increases mortality risk. Traditional methods of detection often rely on visible symptoms, such as fever, rapid breathing, or low blood pressure, which may appear only when the patient’s condition has already worsened.

AI for Sepsis Early Detection: Saving Lives with Speed

ai-for-sepsis-early-detection-saving-lives-with-speed

株式会社プレステージ・インターナショナル（本社：東京都千代田区、代表取締役：玉上 進一、以下「PI」）と、グローバルに事業展開するITソリューションプロバイダーのVMO HOLDINGS TECHNOLOGY JOINT STOCK COMPANY（本社：ベトナム・ハノイ、CEO兼会長：Hoàng Tuấn Hải、以下「VMO」）は、顔と指紋による生体認証を活用し、安全でパスワード不要の本人確認を実現する生体認証アプリケーション「BioAuth」の提供を開始しましたことをお知らせいたします。提供開始を記念し、両社の代表取締役による式典が10月6日に開催されました。<figure class="image"><img src="https://vmo-ho-web-global.s3.ap-southeast-1.amazonaws.com/vmogroup-global/uploads/1759895173217-Cover%201.png"></figure><h3>BioAuth開発の背景：パスワード不要認証の必要性</h3>リモートワークやデジタル化が進む現代において、従来のパスワード認証は時代遅れで危険性が高まっています。近年、金融業界では大規模なサイバー攻撃やデータ漏洩が多発しており、AIツールによってフィッシング詐欺や不正行為はより巧妙になっています。多くの企業にとって、セキュリティ強化とコスト・運用の簡素化の両立は大きな課題です。BioAuthは、これらの課題に対応するために開発されました。 FIDO2規格に基づくBioAuthは、パスワードを不要にすることで、フィッシングやデータ漏洩のリスクを軽減し、より速く、安全で、使いやすいログイン体験を提供します。<h3>BioAuthが提供する機能</h3>BioAuthは、スマートフォンやPCに内蔵された生体認証機能を利用して、本人確認を行います。主な特長は以下の通りです。 &nbsp;<ul><li>パスワード不要の認証: サーバー側でパスワードを保存する必要がなくなります。</li><li>強力な多要素認証（MFA）: 生体認証、ハードウェアキー、デバイスPINなどを追加の認証要素としてサポートします。</li><li>フィッシング耐性: 認証情報が特定のドメインに紐づけられるため、偽サイトでの認証情報再利用を防ぎます。</li><li>クロスプラットフォーム対応: デスクトップ、モバイル、および主要なブラウザ（Chrome、Edge、Safari、Firefox）で動作します。</li><li>なりすまし防止: 顔や指紋による認証により、許可されたユーザーのみがアクセスできます。</li><li>簡単な統合: 既存の業務システムやアプリケーション、シングルサインオン（SSO）環境にシームレスに連携できます。</li></ul><h3>BioAuthのセキュリティ：FIDO2の優位性</h3>BioAuthは、FIDO2パスワードレス規格（FIDO2はFIDO Allianceの商標）に基づいています。この規格では、認証情報が中央サーバーに保存されることはありません 。代わりに、ユーザー自身のデバイス上で安全なキーが作成・使用されるため、認証情報の盗難やフィッシング攻撃のリスクが大幅に減少します。 FIDO Allianceによると、データ侵害の80%以上は、脆弱なパスワードや盗まれたパスワードが原因とされています 。FIDO2はパスワードを完全に排除することで、最大の攻撃経路を取り除きます。 Microsoft, Google, Appleなどの大手IT企業もすでにFIDO2をパスワード不要のログインに採用しており、その拡張性と実用的なセキュリティが証明されています。サービス概要<ul><li>サービス名: 生体認証ログイン</li><li>正式提供開始日: 2025年10月6日</li><li>対応プラットフォーム: Windows 10 &amp; 11、macOS、iOS &amp; iPadOS、Android、Linux&nbsp;</li></ul>提供価値: 「セキュリティ強化」サイバー脅威から顧客の機密データや保険取引を保護します。 「利便性の向上」パスワード不要の迅速な認証により、顧客体験が向上し、保険金請求や契約管理のプロセスが迅速化されます。 「業界特化」保険業界向けに特化しており、コンプライアンスやデータプライバシー規制への対応を支援します。<h3>今後の展望</h3>PIはBioAuthをPIグループ内の各システムに対して展開していきます。 VMOは、BioAuthを各企業、保険会社、医療機関などセキュリティインフラを強化したいと考える組織にとっての「定番」ソリューションにすることを目指していきます。 今後のアップデートでは、以下を予定しています。 &nbsp;<ul><li>改ざん防止の認証記録を可能にするブロックチェーン技術との統合。</li><li>デジタルと物理の両方のセキュリティをシームレスにするための物理アクセスシステム（スマートロックなど）への対応。</li><li>大規模組織向けのエンタープライズレベルのサポート強化。</li><li>PIグループのクライアント向けに、グループ内のすべてのプラットフォームやサービスで安全かつ便利なログインを提供する専用の生体認証ソリューションの提供。</li></ul>

生体認証アプリケーション「BioAuth」の提供開始 〜パスワード不要で安全な本人確認を実現〜

japan-biometric-authentication-application-“bioauth”-launches

Prestige International Inc. (headquarters: Chiyoda-ku, Tokyo; CEO: Shinichi Tamagami; hereinafter “PI”) and VMO HOLDINGS TECHNOLOGY JOINT STOCK COMPANY (headquarters: Hanoi, Vietnam; CEO: Hoàng Tuấn Hải; hereinafter “VMO”), a leading IT solutions provider based in Vietnam, are pleased to announce the launch of “BioAuth”, a biometric authentication application that leverages facial and fingerprint recognition to provide secure, passwordless identity verification.To celebrate the release of this application, a Signing Ceremony by the CEOs of both companies was held on October 6, 2025.<figure class="image"><img src="https://vmo-ho-web-global.s3.ap-southeast-1.amazonaws.com/vmogroup-global/uploads/1759888095087-Cover%201.png"></figure><h3 style="margin-left:0px;">Why BioAuth was born - The Rising Need for Passwordless Authentication</h3>With remote work and digital operations becoming the norm, traditional password-based authentication is proving outdated and risky. The fintech industry has faced major cyberattacks and data breaches in recent years, while AI-driven tools have made phishing and fraud more sophisticated than ever. For many companies, balancing enhanced security with low cost and simplicity is a growing challenge.BioAuth was developed to address these concerns by providing a zero-trust identity verification solution that is easy to deploy, requires no passwords, and ensures strong security through the use of biometric data. BioAuth, built on the FIDO2 standard, eliminates the need for passwords reducing risks of phishing and data leaks while delivering a faster, safer, and user-friendly login experience.<h3 style="margin-left:0px;">What Does BioAuth Offer?</h3>BioAuth enables users to authenticate their identity using the built-in biometric capabilities of their devices like smartphones or computers. Key benefits include:<ul><li>Passwordless authentication : Removes the need for storing passwords in the backend.</li><li>Strong MFA : Supports biometric, hardware keys, or device PINs as an additional factor.</li><li>Phishing resistance : Authentications are bound to the origin (domain), preventing credential reuse on fake sites.</li><li>Cross-platform support : Works on desktops, mobiles, and browsers (Chrome, Edge, Safari, Firefox).</li><li>Impersonation-Proof : Authentication through facial or fingerprint recognition ensures only the authorized user gains access.</li><li>Easy Integration : Works seamlessly with existing business systems and apps, including SSO environments.</li></ul><h3>Why BioAuth Is Secure – The FIDO2 Advantage</h3>BioAuth is built on the FIDO2 Passwordless Standard (FIDO2 is a trademark of the FIDO Alliance). With this standard, authentication credentials are never stored on a central server. Instead, secure keys are created and used directly on the user’s device, which greatly reduces the risk of credential theft or phishing attacks. According to the FIDO Alliance, over 80% of data breaches are caused by weak or stolen passwords. By eliminating passwords entirely, FIDO2 removes the single biggest attack vector. Tech giants like Microsoft, Google, and Apple have already adopted FIDO2 for passwordless login, proving its scalability and real-world security.Service Overview<ul><li>Service Name : Biometric Authentication Login</li><li>Official Launch Date : October 6, 2025</li><li>Supported Platforms : Windows 10 &amp; 11, macOS, iOS &amp; iPadOS, Android, Linux</li></ul>Value Proposition: Enhanced Security : Protects sensitive client data and insurance transactions from cyber threats. User Convenience : Quick, passwordless authentication improves the customer experience and speeds up claim processing or policy management. Industry Focus : Tailored to the insurance domain, supporting compliance and data privacy regulations.<h3>Future Plans</h3>PI plans to deploy BioAuth to each system within the PI group. VMO aim to make BioAuth the go-to solution for each company’s insurance firms, healthcare providers, and other organizations seeking to upgrade their security infrastructure without technical complexity. Future updates will include:<ul><li>Integration with blockchain technology to ensure tamper-proof authentication records.</li><li>Support for physical access systems (e.g., smart locks) for seamless security across digital and physical domains.</li><li>Enhanced enterprise-level support for large organizations.</li><li>Dedicated biometric authentication solutions for PI group clients, providing secure and convenient login across all group platforms and services.</li></ul>

The Strategic Partnership Signing Ceremony between VMO and Prestige International Inc. took place on October 6, 2025, marking a significant milestone in delivering secure, convenient, and phishing-resistant authentication experiences.

VMO x Prestige International Strategic Partnership Signing Ceremony

Biometric Authentication Application “BioAuth” Launches —Enabling Secure, Passwordless Identity Verification

biometric-authentication-application-“bioauth”-launches-—enabling-secure-passwordless-identity-verification

On April 1, 2021, VMO Holdings Technology Joint Stock Company (VMO) held a Ceremony to announce its Vision, Mission &amp; Core Values which has been solidified during the past 10 years of establishment and development. On that enduring journey full of proud milestones was the great leadership of the Board of Directors, in alignment with the consensus of all the members of VMO.&nbsp;Along with the outstanding development and growth, VMO embraces the goal of meeting an increasingly rigorous requirements of the IT market, conquering the satisfaction of significant customers in various large-scale projects. Above all lies the ultimate development goal of VMO, closely tied with its core values, lofty mission, and new vision to bring VMO to a new position, increase its influence and spread more good values to the community.In parallel with the investment and development of human resources and technology, VMO clearly understand the desires and ideal that company needs to implement to make VMO a global technology company. VMO officially announce its Mission, Vision &amp; Core values Statement:&nbsp;OUR VISION&nbsp;To be recognized as a Global Leading IT Company<ul><li>To actualize the innovative idea of clients around the world with professional software development and business consultation services.</li></ul>OUR MISSIONFrom Idea to Reality, From Goodwill to Impact<ul><li>VMO turn&nbsp;the&nbsp;ideas of the clients&nbsp;into valuable products that actively contribute for the betterment of the society.</li></ul>OUR CORE VALUESDesire<ul><li>Desire is the aspiration to achive greatness. We desire, we change, we thrive.</li></ul>Transparency<ul><li>&nbsp;VMO Holdings embraces transparency. Internally, we make sure that every voices are listened. To clients, we build the relationship with goodwill and trust. Transparency is the foundation of sustainable development.</li></ul>Conscientiousness<ul><li>We treat each task&nbsp;with&nbsp;passion and enthusiasm. Dedication is the secret of outstanding efficiency.</li></ul>Synergy&nbsp;<ul><li>We&nbsp;are group&nbsp;of&nbsp;different personalities with a same will&nbsp;and common goal. Synergies is the engine of great teamwork.</li></ul>VMO Holdings Technology Joint Stock Company hopes that a new vision, mission, and core values will serve to achieve company’s development goals, bring company to a new position, upgrade its corporate culture, and create useful values to contribute to the development of global humanity.

On April 1,  VMO officially announced vision, mission and Core values Statement

VMO ANNOUNCED VISION, MISSION, CORE VALUES

vmo-announced-vision-mission-core-values

By reading this article, you will gain valuable insights into the significant advantages of enlisting the expertise of a skilled SAP logistics consultant. It will provide a clear understanding of how such consultants can revolutionize logistics functions, leading to cost reduction, improved operational efficiency, and remarkable professional achievements.

SAP Logistics: Unlocking the Key Benefits, Strategies & Best Practices

This article explores the concepts of SAP logistics business processes and emphasizes the importance of logistics in supply chain optimization

sap-logistics-unlocking-the-key-benefits-strategies-best-practices

On December 24, 2019, VMODEV Hanoi Technology Joint Stock Company officially established a branch of VMO Japan at 〒101-0047 Tokyo , Chiyoda-ku , Uchikanda, 2-14-12, Hoshiya 6th Building No 402, one of World's largest economic centers.&nbsp;Founded in 2012, VMODEV has over 8 years developing and accompanying many European and American businesses, successfully building many technological products from the concept stage to delivering to users, including the product reaches more than 15 million users worldwide.Quality, Flexibility, Speed are the core values that the leaders and employees of VMODEV have pursued for nearly 10 years. Identifying Japan as the next important market in the company's long-term development strategy, Mr. Hoang Tuan Hai, CEO of VMODEV said: “The Japanese IT market is a large market with strict requirements for quality. We believe that by understanding the culture of our team in Japan, VMODEV can completely bring success to Japanese businesses, such as the satisfaction we bring to clients in the Europe and America, EU markets”.In Japan, VMODEV wishes to assist clients in deploying digital business models, as well as applying IT platforms and new technologies such as AI, Cloud, RPA ... to improve productivity and efficiency for current business models. VMODEV will provide high quality IT human resources for Japanese businesses. It is expected that after Japan, VMODEV will continue to expand more branches in countries such as the USA, Singapore, Korea ... in the near future.&nbsp;More information about VMODEVVMODEV was founded in 2012 by technology enthusiasts and desires to contribute and bring practical values to society. Currently the company has 4 working offices and its headquarters are located in Hanoi, Vietnam. Over 8 years of working with many partners in Europe, America, EU, Asia ... VMODEV has developed more than 300 projects with clients from 11 countries. The products we design and deploy reach more than 45 million users globally.&nbsp;Contact information<figure class="table"><table><tbody><tr><td>VMODEV HANOI TECHNOLOGY JOINT STOCK COMPANYAddess: 15th Floor, TTC Tower, 19 Duy Tan st., Dich Vong Hau ward., Cau Giay dist., Hanoi 100000Phone number: +84 24 3312 0103Website: <a href="https://www.vmodev.com/">https://www.vmodev.com</a>Email: <a href="mailto:info@vmodev.com">info@vmodev.com</a></td><td>VMO JAPAN JOINT STOCK COMPANYAddress: 〒101-0047 Tokyo , Chiyoda-ku , Uchikanda, 2-14-12, Hoshiya 6th Building No 402Phone number: 03-4400-2818Website: <a href="https://www.vmodev.jp/">https://www.vmodev.jp</a>Email: <a href="mailto:infojp@vmodev.com">infojp@vmodev.com</a></td></tr></tbody></table></figure>&nbsp;

On December 24, 2019, VMODEV officially established a branch of VMO Japan

You share it

We care IT

LET'S BUILD SOMETHING GREAT TOGETHER